RxDoctor Payments Data

Natasha Salazar

Physician Assistant · Downey, CANPI 1215401674

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $27,853 of the $31,112 with a category attached, or 89.5%. It is spread thinly across 60 manufacturers, the largest accounting for just 14.0% — the pattern of someone who eats at a lot of different presentations. Among physician assistant clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$31,112in general payments, 2019–2025

Across 1,268 payments — averaging $24.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$4K
  • Eisai Inc.$2K
  • Incyte Corporation$2K
  • Johnson & Johnson$1K
  • AstraZeneca$1K
  • Pfizer$1K
  • plus $19K from 54 others

What the payments were for

  • Food & beverage$27,85390%
  • Education$9093%
  • Other$2,3508%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novartis131$4,366
Eisai Inc.74$1,732
Incyte Corporation72$1,675
Johnson & Johnson(2 entities)50$1,423
AstraZeneca(2 entities)62$1,404
Pfizer64$1,194
Bristol Myers Squibb55$1,129
E.r. Squibb & Sons, L.L.C.61$1,091
Merck43$1,054
Takeda Pharmaceuticals U.S.A., Inc.35$890
Lilly USA, LLC36$775
Astellas Pharma US Inc29$742
Bayer32$718
Daiichi Sankyo Inc.27$717
Gilead(2 entities)27$699
GSK35$681
AbbVie36$664
Seagen Inc.22$612
Sobi, Inc21$611
Amgen24$594
Sanofi18$513
Karyopharm Therapeutics Inc.20$487
Pharmacyclics LLC, An Abbvie Company24$471
Exelixis Inc.12$406
Regeneron Healthcare Solutions, Inc.10$402
Genentech USA, Inc.14$361
Array Biopharma Inc19$326
Puma Biotechnology, Inc.12$295
Sumitomo Pharma America, Inc.14$295
Pharmaessentia USA Corporation6$287
AVEO Pharmaceuticals, Inc.11$268
Stemline Therapeutics Inc.11$265
Beigene USA, Inc.10$258
Boehringer Ingelheim12$245
Rigel Pharmaceuticals, Inc.11$231
EMD Serono, Inc.10$198
CTI Biopharma Corp.4$184
Servier Pharmaceuticals LLC5$183
Syndax Pharmaceuticals, Inc.2$177
Taiho Oncology, Inc.7$153
Recordati_rare_diseases_inc.7$148
Blueprint Medicines Corporation6$143
Myovant Sciences Inc.7$140
Ipsen Biopharmaceuticals, Inc6$132
Morphosys, US Inc.6$130
Sanofi-aventis U.S. LLC1$100
Agios Pharmaceuticals, Inc.4$88
Dendreon Pharmaceuticals LLC3$85
GE HealthCare3$82
Azurity Pharmaceuticals, Inc.3$81
CSL Behring3$73
Kyowa Kirin, Inc.3$73
Geron Corporation3$72
Adaptive Biotechnologies Corporation2$68
Iovance Biotherapeutics, Inc.3$67
Dova Pharmaceuticals3$63
Alnylam Pharmaceuticals Inc.2$52
G1 Therapeutics, Inc.2$50
Pharmacosmos Therapeutics Inc.2$48
Janssen Scientific Affairs, LLC1$48

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$31,112 in reported general payments places this provider in the 95th percentile of 10,423 physician assistant providers in California.

See all physician assistant providers in California

Most prescribed under Part D

DrugClaimsCost to plans & patients
RevlimidLenalidomide34$586,136
ErleadaApalutamide35$469,322
JakafiRuxolitinib Phosphate24$386,083
Lenalidomide19$337,094
TagrissoOsimertinib Mesylate17$293,775
CalquenceAcalabrutinib Maleate16$215,432
VenclextaVenetoclax17$166,328
KisqaliRibociclib Succinate13$120,577
Lupron DepotLeuprolide Acetate17$89,819
Abiraterone Acetate22$64,254
OrgovyxRelugolix16$40,586
EliquisApixaban42$26,876
Imatinib Mesylate20$14,641
OxycontinOxycodone Hcl15$6,675
Letrozole92$1,775

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Bristol Myers SquibbRevlimid$1,129$586,13634 claims
AstraZenecaTagrisso, Calquence$1,404$509,20733 claims
Johnson & JohnsonErleada$1,423$469,32235 claims
Incyte CorporationJakafi$1,675$386,08324 claims
AbbVieVenclexta, Lupron Depot$664$256,14634 claims
NovartisKisqali$4,366$120,57713 claims
Janssen Scientific Affairs, LLCAbiraterone Acetate$48$64,25422 claims
Sumitomo Pharma America, Inc.Orgovyx$295$40,58616 claims
PfizerEliquis$1,194$26,87642 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 10,423 physician assistant providers in California.

Other physician assistant in Downey

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →